DentalMonitoring Sets New Standard In Orthodontic Remote Monitoring With De Novo Approval By the U.S. Food and Drug Administration (FDA).
Retrieved on:
понедельник, мая 20, 2024
Apps, Applications, Technology, Medical Devices, FDA, Dental, Health Technology, Health, General Health, Artificial Intelligence, Orthodontics, Patient, Dentistry, Medical device, Food, Algorithm, Artificiality, Diagnosis, Software, Artificial intelligence, Dental care, Smartphone, Caregiver, De novo, Research, Deep learning, Communication, Classification, Multimedia, STL
DentalMonitoring®, the leader in AI-powered remote monitoring for orthodontic treatment, has received De Novo approval from the U.S. Food and Drug Administration (FDA) for the DentalMonitoring solution to be used by orthodontists in optimizing clinical care.
Key Points:
- DentalMonitoring®, the leader in AI-powered remote monitoring for orthodontic treatment, has received De Novo approval from the U.S. Food and Drug Administration (FDA) for the DentalMonitoring solution to be used by orthodontists in optimizing clinical care.
- View the full release here: https://www.businesswire.com/news/home/20240520240852/en/
DentalMonitoring Sets New Standard in Orthodontic Remote Monitoring with De Novo Approval by the U.S. Food and Drug Administration (FDA) (Graphic: Business Wire)
DentalMonitoring is a medical device software using image processing algorithms to analyze pictures of the oral cavity (hereinafter Scans). - DentalMonitoring is indicated for use for patients over the age of 6 and reports results solely on permanent teeth.
- The product is designed to assist healthcare professionals in remotely monitoring dental treatments, orthodontic treatments, oral health, and treatment progress.